TGen & HonorHealth Initiate COVID-19 Combination Therapy of Atovaquone, Azithromycin
May 06, 2020
May 06, 2020
SCOTTSDALE, Arizona, May 6 -- The Translational Genomics Research Institute issued the following news release:
The HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection. The clinical trial, conducted in collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is funded as an investigator-initiated clin . . .
The HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection. The clinical trial, conducted in collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is funded as an investigator-initiated clin . . .